D Pelletier

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint 3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain
    D Pelletier
    Department of Neurology, University of California, San Francisco, USA
    Magn Reson Imaging 20:599-606. 2002
  2. pmc Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures
    D T Okuda
    UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, California 94117, USA
    Brain 132:250-9. 2009
  3. doi request reprint Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome
    D T Okuda
    Department of Neurology, University of California San Francisco, UCSF Multiple Sclerosis Center, San Francisco, CA 94117, USA
    Neurology 72:800-5. 2009
  4. pmc Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging
    J Oh
    Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco 94107, USA
    J Neurol Neurosurg Psychiatry 75:1281-6. 2004
  5. pmc MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy
    D Pelletier
    Department of Neurology, University of California at San Francisco, San Francisco, CA, USA
    J Neurol Neurosurg Psychiatry 74:950-2. 2003
  6. pmc Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
    D T Okuda
    Department of Neurology, UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, USA
    Neurology 76:686-92. 2011
  7. pmc Regional grey matter atrophy in clinically isolated syndromes at presentation
    R G Henry
    Department of Radiology, University of California at San Francisco, California, USA
    J Neurol Neurosurg Psychiatry 79:1236-44. 2008
  8. pmc Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study
    E Waubant
    University of California, San Francisco, USA
    Neurology 78:1171-8. 2012
  9. pmc Estimation of metabolite T1 relaxation times using tissue specific analysis, signal averaging and bootstrapping from magnetic resonance spectroscopic imaging data
    H Ratiney
    Department of Neurology, University of California, 185 Berry Street, Box 0946, San Francisco, CA 94107, USA
    MAGMA 20:143-55. 2007
  10. ncbi request reprint T2 relaxation time histograms in multiple sclerosis
    D Grenier
    Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco, California, USA
    Magn Reson Imaging 20:733-41. 2002

Collaborators

Detail Information

Publications15

  1. ncbi request reprint 3-D echo planar (1)HMRS imaging in MS: metabolite comparison from supratentorial vs. central brain
    D Pelletier
    Department of Neurology, University of California, San Francisco, USA
    Magn Reson Imaging 20:599-606. 2002
    ....
  2. pmc Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures
    D T Okuda
    UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, California 94117, USA
    Brain 132:250-9. 2009
    ....
  3. doi request reprint Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome
    D T Okuda
    Department of Neurology, University of California San Francisco, UCSF Multiple Sclerosis Center, San Francisco, CA 94117, USA
    Neurology 72:800-5. 2009
    ..Routinely encountered in clinical practice, the natural history or evolution of such individuals with respect to their risk of developing multiple sclerosis (MS) is unclear...
  4. pmc Mechanisms of normal appearing corpus callosum injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and 1H MRS imaging
    J Oh
    Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco 94107, USA
    J Neurol Neurosurg Psychiatry 75:1281-6. 2004
    ..To investigate the extent of tissue damage in a region of normal appearing corpus callosum (NACC) for different forms of multiple sclerosis (MS) using diffusion tensor and proton magnetic resonance (MR) spectroscopic imaging...
  5. pmc MRI lesion volume heterogeneity in primary progressive MS in relation with axonal damage and brain atrophy
    D Pelletier
    Department of Neurology, University of California at San Francisco, San Francisco, CA, USA
    J Neurol Neurosurg Psychiatry 74:950-2. 2003
    ..To investigate whether axonal damage in primary progressive (PP) multiple sclerosis (MS), as measured by proton magnetic resonance spectroscopy (HMRS) imaging and brain atrophy, is a function of T2 weighted brain lesion volume...
  6. pmc Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
    D T Okuda
    Department of Neurology, UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, USA
    Neurology 76:686-92. 2011
    ....
  7. pmc Regional grey matter atrophy in clinically isolated syndromes at presentation
    R G Henry
    Department of Radiology, University of California at San Francisco, California, USA
    J Neurol Neurosurg Psychiatry 79:1236-44. 2008
    ..Voxel-based analyses allow detection of regional atrophy throughout the brain and, therefore, may be sensitive to regional atrophy in CIS patients, and these changes may correspond with clinical disability...
  8. pmc Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study
    E Waubant
    University of California, San Francisco, USA
    Neurology 78:1171-8. 2012
    ..To test efficacy and safety of atorvastatin in subjects with clinically isolated syndrome (CIS)...
  9. pmc Estimation of metabolite T1 relaxation times using tissue specific analysis, signal averaging and bootstrapping from magnetic resonance spectroscopic imaging data
    H Ratiney
    Department of Neurology, University of California, 185 Berry Street, Box 0946, San Francisco, CA 94107, USA
    MAGMA 20:143-55. 2007
    ....
  10. ncbi request reprint T2 relaxation time histograms in multiple sclerosis
    D Grenier
    Magnetic Resonance Science Center, Department of Radiology, University of California, San Francisco, California, USA
    Magn Reson Imaging 20:733-41. 2002
    ..The results of this study showed that the method is easy to implement and may be used to characterize MS pathology...
  11. doi request reprint Retinal axonal loss in very early stages of multiple sclerosis
    A H Maghzi
    Department of Neurology, University of California San Francisco, San Francisco, CA, USA
    Eur J Neurol 22:1138-41. 2015
    ..Our aim was to study the association between time-domain optical coherence tomography measures and clinical and magnetic resonance imaging outcomes in early MS...
  12. pmc Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures
    E M Mowry
    Department of Neurology, University of California, San Francisco, 94117, USA
    Neurology 72:1760-5. 2009
    ..Health-related quality of life (HRQOL) is reduced in multiple sclerosis (MS). It is unclear whether HRQOL is associated with white matter lesion burden or measures of brain atrophy...
  13. pmc HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course
    L F Barcellos
    Department of Neurology, University of California at San Francisco, San Francisco, CA, USA
    Am J Hum Genet 72:710-6. 2003
    ..Concepts of the molecular mechanisms that underlie linkage and association of the human leukocyte antigen (HLA) region to MS need to be revised to accommodate these data...
  14. ncbi request reprint Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b
    S Narayanan
    Montreal Neurological Institute, Quebec, Canada
    J Neurol 248:979-86. 2001
    ..03). Our data suggest that, in addition to losing axons, patients with chronic multiple sclerosis suffer from chronic, sublethal axonal injury that is at least partially reversible with interferon beta-lb therapy...
  15. pmc Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors
    Roman L Bogorad
    Institut National de la Santé et de la Recherche Médicale U845, Equipe PRL, GH et Tumeurs, Centre de Recherche Croissance et Signalisation, F 75015 Paris, France
    Proc Natl Acad Sci U S A 105:14533-8. 2008
    ..Hallmarks of constitutive activity were all reversed by a specific PrlR antagonist, which opens potential therapeutic approaches for MFA, or any other disease that could be associated with this mutation in future...